Views & Analysis | Perspectives on pharma industry issues

Oncology

Building a Phase I oncology centre

The question is not whether an institution should ultimately develop Phase Ia capability. It is when the organisation is ready.

Patients

Older couple high five each other on bicycles at top of hill

The strategic opportunity: Owning the behaviour layer

Behaviour is the layer that lifestyle, physical performance, and nutrition – together – occupy.

Sales & Marketing

Media Partner

Why BIO-Europe 2026 matters: The evolution of strategic biop...

2026 marks a significant evolution for BIO-Europe.

Digital

AI is redefining decision-making in biopharma R&D

AI has kickstarted a new wave of innovation in biopharma R&D.

Patients

pharmaphorum podcast Episode 273, James Davis, PA Consulting

Deliver prevention at scale, PA Consulting’s James Davis

James Davis, a healthcare expert at PA Consulting, discusses the digital foundations needed to unlock a prevention first NHS.

Patients

5 patient travel strategies to impact enrolment diversity in...

According to the latest CISCRP report, “having to travel to the study clinic” is patients’ top-cited participation burden

R&D

Supply chain resilience in pharma: Delivering consistency am...

In an interconnected economy, industries operating on an international scale are increasingly vulnerable to supply chain disruption.

Patients

The high cost of inequality: High US healthcare spend falls ...

Healthcare in the US is facing a cost crisis and one part of the puzzle could be to address the inequality that persists within the system.

Sales & Marketing

Media Partner

Why BIO-Europe 2026 matters: The evolution of strategic biop...

2026 marks a significant evolution for BIO-Europe.

Sales & Marketing

Recruitment concept graphic on beige background

Changing Faces: Agency, consultancy, and investor hires, Jun...

Agencies, consultancies, investment groups, and wider services firms saw significant talent movement across June and July.

Digital

AI is redefining decision-making in biopharma R&D

AI has kickstarted a new wave of innovation in biopharma R&D.

Digital

Technology solutions for smarter clinical trials: Inventus

In an exclusive video interview, Steve Sanghera – CEO and co-founder of Inventus – sat down with pharmaphorum to discuss the company's journey & ethos

Market Access

What India can learn from Kinvard Bio

India needs its own version of pull, designed for an Indian payer mix, an Indian procurement structure, and an Indian distributor network.

Market Access

The new commercialisation playbook: What BIO 2026 taught eme...

BIO International focused on how emerging biotech companies should approach their first product launch outside the United States, typically in Europe.